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Objective: To investigate voice characteristics and exercise related respiratory
symptoms in extremely preterm born 11-year-old children, focusing particularly on
associations with management of a patent ductus arteriosus (PDA).
Study design: Prospective follow-up of all children born in Norway during 1999–2000 at
gestational age <28 weeks or with birthweight <1,000 g. Neonatal data were obtained
prospectively on custom-made registration forms completed by neonatologists. Voice
characteristics and exercise related respiratory symptoms were obtained at 11 years by
parental questionnaires.
Result: Questionnaires were returned for 228/372 (61%) eligible children, of whom 137
had no history of PDA. PDA had been noted in 91 participants, of whom 36 had been
treated conservatively, 21 with indomethacin, and 34 with surgery. Compared to the
children treated with indomethacin or conservatively, the odds ratio (95% confidence
interval) for the surgically treated children were 3.4 (1.3; 9.2) for having breathing
problems during exercise, 16.9 (2.0; 143.0) for having a hoarse voice, 4.7 (1.3; 16.7)
for a voice that breaks when shouting, 4.6 (1.1; 19.1) for a voice that disturbs singing,
and 3.7 (1.1; 12.3) for problems shouting or speaking loudly. The significance of surgery
per se was uncertain since the duration of mechanical ventilation was associated with
the same outcomes.
Conclusion: Extremely preterm born children with a neonatal history of PDA surgery
had more problems with voice and breathing during exercise in mid-childhood than those
whose PDA had been handled otherwise. The study underlines the causal heterogeneity
of exercise related respiratory symptoms in preterm born children.
Keywords: patent ductus arteriosus, extremely premature infant, extremely low birth weight infant, voice quality,
respiratory symptoms, cohort study
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INTRODUCTION
Extremely preterm (EP) birth may lead to long-term
complications, including respiratory problems of various
etiologies (1). Survival at this early stage requires respiratory
interventions, such as oxygen treatment and positive pressure
ventilation, often with endotracheal intubation and mechanical
ventilation (2, 3). Most of these lifesaving measures also cause
various types of airway injuries with long-term consequences,
challenging the diagnostic skills of health care providers (4–6).
Asthma, by far the most prevalent airway disorder, tends
to be a first diagnostic option in young people with airway
symptoms, often solely based on parental reports (7, 8). This
practice inevitably leads to diagnostic errors, and is particularly
unfortunate in EP-born individuals, given their wide causal
repertoire (9–11). For example, bronchial obstruction and
hyperresponsiveness are well described features after EP-birth
as well as in asthma (12–16). Although linked to different
immunological profiles (14, 16–19), large proportions of EP-
born children are exposed to asthma medication (20). Recent
literature has highlighted that also upper airway pathology
creates respiratory symptoms that are misunderstood as asthma
in EP-born children (21–23). We should keep in mind that the
larynx is the narrowest part of the airway tree, representing a
large proportion of total airway resistance (24). Thus, even minor
injuries might hamper airflow when ventilatory requirements are
high, such as during exercise. The larynx might be traumatized
from repeated intubations or from prolonged use of mechanical
ventilation (21, 25, 26). Moreover, surgical treatment of a patent
ductus arteriosus (PDA) has been linked to left vocal cord
paralysis (LVCP) in several studies, explained by the close
proximity between the PDA and the left recurrent laryngeal nerve
(11, 27, 28). Few studies have investigated symptoms of upper
airway abnormalities in EP-born children (21, 26).We needmore
knowledge on these issues in order to develop evidence based
guidelines for work-up of respiratory complaints in this group.
Previous studies have suggested a role for laryngoscopy (11, 29–
31); however, this notion needs support from more studies.
In this study, we used parental reports of voice abnormalities
and exercise related respiratory symptoms to explore potential
presence of upper airway pathology in a nationwide cohort
of 11-year-old children born extremely preterm. Further, we
investigated associations between these symptoms and neonatal
PDA and its management.
MATERIALS AND METHODS
Study Population
This investigation was part of a Norwegian nationwide
prospective cohort study of all children born with gestational age
(GA) 230–276 weeks or birth weight (BW) below 1,000 g born
during 1999–2000 (2). Of 638 children, 174 were stillborn or died
in the delivery room, 86 died in the neonatal intensive care unit
(NICU), and two declined participation (2). Three children died
after discharge from NICU and one died later during the follow-
up period, leaving 372 children eligible for inclusion. A “clinically
significant PDA” had been diagnosed in 143 survivors, of whom
47 had undergone PDA surgery (Figure 1).
Sources and Collection of Data
Information on the neonatal characteristic and clinical course
in the NICU was obtained from compulsory notifications to
the Medical Birth Registry of Norway and custom-made study
registration forms (2). GA was based on ultrasound at 17–
18 weeks of gestation. Small for gestational age (SGA) was
defined as a BW less than the 5th. percentile for GA and gender
according to Norwegian growth curves (32). Bronchopulmonary
dysplasia (BPD) was defined as still dependency on oxygen
supplementation at 36 weeks’ GA. The respiratory medical
history of this cohort has been published (20, 33). PDA was
diagnosed at the discretion of the participating NICUs, with
algorithms based on echocardiographic assessment of the left
atrium to the aortic root ratio (above 1.3–1.5 depending on
clinical situation) and clinical signs as listed by Evans in
1993 (bounding hyper dynamic pulses and signs of cardiac or
respiratory insufficiency) (34). Infants with a diagnosed PDA
were treated either conservatively with fluid retention, diuretics,
or unspecified symptomatic support, or the PDA was actively
treated with either indomethacin or surgical closure performed
by suture or clip.
At 11 years of age, data on previous and current symptoms
were obtained from parental questionnaires. The questions:
“Does the child have breathing problems beyond what is normal
during physical exertion?” and “Does the child make ‘scraping
sounds’ or other abnormal sounds from the throat during physical
exertion?” were custom made for the project. The questions
regarding exercise related wheeze, asthma (ever) and use of
asthma medications were obtained from the International Study
of Asthma and Allergies in Childhood questionnaire (ISAAC)
(35). Current asthma was defined as [1] a physician’s diagnosis
of asthma combined with either respiratory symptoms or use
of asthma medication in the previous 12 months, or [2] asthma
medication and symptoms in the past 12 months even if
no recall of prior physician’s diagnosis. Asthma medication
included inhaled corticosteroids, short or long acting β2-agonists
and oral leukotriene modifiers. The six questions about voice
characteristics were based on the Voice Handicap Index version
5 questionnaire (36). All questions were translated to Norwegian
language, and the questions analyzed in this study are described
in Supplementary Table I.
Statistical Methods
Outcome variables were voice characteristics and exercise related
respiratory symptoms obtained from questionnaires at age 11
years. We investigated these binary outcomes in relation to a
neonatal history of PDA vs. no PDA, and in relation to the
mode of treatment in the children with a neonatal history of
PDA. Those who underwent surgical closure (labeled “surgery”)
were compared with those who did not undergo surgery (“no-
surgery”). The “no-surgery” group included children who had
been treated conservatively or with indomethacin, as initial
analyses comparing the conservative and the indomethacin
group showed that they did not differ in terms of neonatal
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FIGURE 1 | Follow-up of a national cohort of all 372 children born extremely preterm in Norway during 1999 and 2000 at a gestational age <28 weeks and/or with a
birth weight <1,000 g, according to management of patent ductus arteriosus in the neonatal period.
variables and outcomes. Questions with graded response
alternatives were transposed to dichotomous variables (no/yes)
(Supplementary Table I).
Group differences were tested using independent samples t-
test and chi-square test or Fischer‘s exact test, as appropriate. We
further investigated associations by odds ratios (OR) with 95%
confidence intervals (CI) using binary logistic regression. The
ORs were estimated with crude and adjusted models, adjusted
for days on mechanical ventilation and GA. We did not present
analyses with adjustment for postnatal steroids because there is
no causal link between use of postnatal steroids and PDA surgery.
Potential confounders were adjusted for one by one in order to
avoid that the total number of variables entered into the final
regression equations exceeded 1/10 of the number of events. All
analyses were performed using IBM SPSS statistics version 24
for Windows.
Ethics
The regional ethical committee of Western Norway approved the
study (REC number 2009/2271). Informed written consents were
obtained from the participant’s parents.
RESULTS
Subjects
Questionnaires were returned for 228 of the 372 (61%) eligible
children; including 91 of 143 children with a neonatal history
of PDA and 137 of 228 children without PDA. Among the
91 children with PDA, 34 (37%) were treated with surgery, 36
(40%) received conservative treatment, and 21 (23%) received
indomethacin (Figure 1). Six children in the surgery group had
received indomethacin. Among the surgically treated children,
those lost to follow-up had lower GA and BW, and spent
more days on invasive mechanical ventilation. Further details
on neonatal characteristics of children who were assessed
and lost to follow-up at 11 years of age are presented in
Supplementary Table II.
Perinatal Characteristics
The children with a neonatal history of a PDA had lower GA,
were more often intubated at birth, received more postnatal
steroids and surfactant, had spent more days on continuous
positive airway pressure (CPAP) and had more often developed
BPD compared to children without PDA (Table 1). Those with
PDA who were treated with surgical closure were born at lower
GA, had spent more days on mechanical ventilation, and more
often received postnatal steroids compared to the children with
PDA who were not treated with surgery.
Questionnaire Based Data of Respiratory
and Voice Related Symptoms at 11 Years
of Age
Our data showed that exercise related respiratory symptoms
or voice problems were more common in children with- than
Frontiers in Pediatrics | www.frontiersin.org 3 April 2020 | Volume 8 | Article 150
Engeseth et al. Voice/Respiratory Symptoms After PDA




















GA (weeks) 27.07 (1.7) 26.07 (1.4) 26.32 (1.3) 25.6 (1.4) 1.03 (0.6–1.4) <0.01 0.73 (0.15–1.31) 0.01
Birth weight (gram) 865 (166.1) 866 (162.8) 886 (154.5) 832 (172.9) −0.95 (-44.6–43.0) 0.97 53.5 (-16.1–123.0) 0.13
Start of PDA treatment, days after birth §
Indomethacin 10.7 (7.4) 9.5 (5.2)
PDA Surgery 13.4 (9.6)
Days on invasive mechanical ventilation
Mean (SD) 7.1 (15.7) 11.1 (14.0) 8.1 (9.3) 16.2 (18.6) −3.96 (−7.8–0.04) 0.05 8.1 (1.2–15.0) 0.02
Median (range) 2 (0–113) 6 (0–83) 5 (0–44) 10.0 (0–83)
Days on CPAP 22.8 (18.8) 28.4 (19.4) 29.7 (19.7) 26.1 (18.8) −5.5 (−10.5; −0.6) 0.03 3.69 (−4.7–12.0) 0.38
Characteristics N (%)
SGA 36 (26) 8 (9) 7 (12) 1 (3) 0.001 0.25
Sex (female) 63 (46) 41 (45) 28 (49) 13 (38) 0.185 0.31
BPD (O2-suppl. at 36 weeks GA) 49 (36) 62 (68) 35 (61) 27 (79) <0.001 0.08
Tracheal intubation at birth* 83 (64) 75 (82) 45 (79) 30 (88) 0.001 0.42
Surfactant 103 (75) 85 (93) 54 (95) 31 (91) <0.001 0.67
Prenatal steroids 103 (75) 57 (63) 36 (63) 21 (62) 0.04 0.89
Postnatal steroids 37 (27) 45 (50) 23 (40) 22 (65) 0.001 0.03
Cerebral Palsy at 5 years of age 6 (4) 6 (7) 4 (7) 2 (6) 0.55 0.99
Independent t-test, chi-square test or Fischer’s exact test was used as appropriate.
BPD, bronchopulmonary dysplasia; CI, confidence interval; CPAP, continuous positive airway pressure. GA, gestational age; IMV, invasive mechanical ventilation; PDA, patent ductus
arteriosus; SD, standard deviation; SGA, small for gestational age.
*Missing data: Tracheal intubation at birth: Eight cases missing from the “no PDA” group and two cases missing from the “PDA”/“PDA, no surgery” groups. §Start of PDA treatment: Data
are missing for nine children regarding age at day of PDA surgery. 21 children in the “PDA, no surgery” group received indomethacin treatment and six children in the “PDA, surgery”
group received indomethacin treatment before surgery. Values in bold indicates a p-value of less than 0.05.
FIGURE 2 | Reported respiratory symptoms during or after physical activity among a national cohort of extremely preterm born children at 11 years of age according
to diagnosis and treatment of patent ductus arteriosus in the neonatal period.
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FIGURE 3 | Reported voice characteristics among a national cohort of extremely preterm born children at the age of 11 years according to diagnosis and
management of patent ductus arteriosus in the neonatal period.
without a neonatal history of PDA. However, differences were
only statistically significant for scraping sound during physical
exertion (Figures 2, 3). There were no important differences in
reports of asthma or use of asthma medications (Figure 4).
In children who had a neonatal history of PDA, surgical
closure was associated with more frequent reports of breathing
problems during physical exertion (Figure 2) and voice related
symptoms (Figure 3) compared to the no-surgery group. There
were no differences between the surgery group and the no-
surgery group regarding current asthma, current use of asthma
medication or ever having had asthma, but a higher proportion
of the surgery group had previously received asthma medication
compared to the no-surgery group (Figure 4). In total, one or
more symptoms related to respiration during exertion or voice
were reported for 20 (61%) of the participants in the surgery
group and 17 (31%) in the no-surgery group (p= 0.006).
Logistic Regression Analyses
Exercise Related Respiratory Symptoms
The odds ratio (OR) for having scraping sounds during physical
exertion was increased among children with a PDA diagnosis
(OR: 10.25; 95% CI: 2.24–47.0; p = 0.03) compared to the
group without PDA, but not for other symptoms (not shown
in tables). Among children with PDA, the crude odds of having
breathing problems during physical exertion were higher in the
surgery group relative to the no-surgery group (Table 2). After
adjustment for number of days on mechanical ventilation, the
OR of having breathing problems during physical exertion was
still increased, but confidence intervals were wide. Adjusting for
GA did not have impact on the OR.
Voice Characteristics
The OR for having symptoms related to voice was not increased
among children with a PDA diagnosis, compared to the group
without PDA. Among children with PDA, the crude odds of
having a hoarse voice, a voice that breaks when shouting, a
voice that affects participation in singing or a voice that leads
to problems talking loudly/shout, were higher in the surgery
group compared to the no-surgery group (Table 3). Adjusted
for number of days on mechanical ventilation, the ORs were no
longer increased for any of the voice characteristics. Adjusted for
GA, the ORs were still increased for having a hoarse voice or a
voice that cracks when shouting.
DISCUSSION
We found that voice and exercise related respiratory symptoms
were more common in 11-year-old children born extremely
preterm with a neonatal history of PDA surgery, compared to
children whose PDA had been managed otherwise. However, the
significance of surgery per se remains uncertain since adjusting
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FIGURE 4 | Reports of asthma and use of asthma medications among a national cohort of extremely preterm born children at 11 years of age according to diagnosis
and treatment of patent ductus arteriosus in the neonatal period.
TABLE 2 | The odds ratio of having respiratory symptoms during or after physical activity at 11 years of age in a national cohort of extremely preterm born children
according to treatment for patent ductus arteriosus (no surgery vs. surgery) in the neonatal period.
PDA treatment N (%) Crude OR (95% CI) p aOR1 (95% CI) p aOR2 (95% CI) p
Breathing problems No surgery 9/56 (16) 3.4 (1.3–9.2) 0.02 2.6 (0.9–7.4) 0.08 3.2 (1.1–9.0) 0.03
Surgery 13/33 (39)
Wheeze No surgery 7/57 (12) 2.6 (0.9–7.7) 0.09 2.5 (0.8–7.9) 0.11 2.8 (0.9–8.8) 0.08
Surgery 9/34 (27)
Scraping sound No surgery 5/57 (9) 2.7 (0.8–9.3) 0.12 1.8 (0.5–6.8) 0.41 2.4 (0.7–8.7) 0.17
Surgery 7/34 (21)
Breathing problems: proportion who answered “a little more than normal” or “a lot more than normal” to question 1: “Does the child have breathing problems beyond what is normal
during physical exertion?” Wheeze: Proportion who answered “yes” to question 2: “During the last 12 months, has the child had heavy breathing or wheezing from the chest during or
after physical exercise or play?” Scraping sound: proportion who answered “a little” or “a lot” to question 3: “Does the child make ≪scraping sounds≫ or other abnormal sounds from
the throat during physical exertion?” aOR1, adjusted for total number of days on invasive mechanical ventilation. aOR2, adjusted for gestational age; CI, confidence interval; OR, odds
ratio; PDA, patent ductus arteriosus. Values in bold indicates a p-value of less than 0.05.
for days of mechanical ventilation significantly weakened
the associations.
Previous studies have described that EP-born children with
left vocal fold paralysis (LVCP) following PDA surgery had
prolonged dependency of mechanical ventilation compared to
surgically treated children without LVCP (11, 28, 37, 38).
Unfortunately, the respective duration of mechanical ventilation
before vs. after surgery could not be estimated in our study.
Thus, prolonged mechanical ventilation in the surgery group
could be caused by a possible LVCP or other complications
following surgery (39). However, it could also reflect confounding
by indication; i.e., those treated surgically were also those with the
most severe disease, therefore spendingmost days ventilated (40).
Both mechanisms might have been operative, but we do not have
data to disentangle this scenario. Days on mechanical ventilation
was associated with symptoms in all subgroups, also in those with
no history of PDA, although at a lower odds ratio. The observed
association (co-linearity) between days onmechanical ventilation
and surgical PDA treatment complicates interpretations of the
regression models. We therefore report both adjusted and
unadjusted data in Tables 2, 3. However, taken together the data
indicate that neonatal PDA surgery leads to more voice and
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TABLE 3 | The odds ratio of having voice symptoms at 11 years of age in a national cohort of extremely preterm born children according to treatment (no surgery vs.
surgery) for patent ductus arteriosus in the neonatal period.
PDA treatment N (%) Crude OR (95% CI) p aOR1 (95% CI) p aOR2 (95% CI) p
Hoarse voice No surgery 1/56 (2) 16.9 (2.0–143) 0.009 9.6 (1.0–93.8) 0.05 14.1 (1.6–122) 0.02
Surgery 8/34 (24)
Voice cracks when the child shouts No surgery 4/56 (7) 4.7 (1.3–16.7) 0.017 3.2 (1.2–20.7) 0.10 3.9 (1.1–14.4) 0.04
Surgery 9/34 (27)
Voice influences participation in
singing
No surgery 3/56 (5) 4.6 (1.1–19.1) 0.04 2.8 (0.6–13.1) 0.19 3.7 (0.9–16.2) 0.08
Surgery 7/34 (21)
Problems shouting or talking loudly No surgery 5/57 (9) 3.7 (1.1–12.3) 0.03 2.6 (0.7–9.3) 0.14 3.2 (0.9–10.9) 0.07
Surgery 9/34 (27)
Weak or unclear voice No surgery 9/57 (16) 1.6 (0.6–4.8) 0.36 1.0 (0.3–3.4) 0.96 1.5 (0.5–4.6) 0.46
Surgery 8/34 (24)
Voice influences participation in
school or social activities
No surgery 7/57 (12) 1.9 (0.6–5.8) 0.29 1.3 (0.4–4.4) 0.73 1.8 (0.5–5.8) 0.35
Surgery 7/34 (21)
N (%) represents proportion who answered affirmative (“A little,” “Moderately,” “A lot more” or “Extremely”) to the following questions: Hoarse voice: “Is the child‘s voice more hoarse
compared to other children at the same age? Voice cracks when the child shouts: Does the voice ≪crack≫ when the child shouts?,” Voice influences participation in singing: “Does
the voice influence the child‘s participation in singing?,” Problems shouting or talking loudly: “Does the child have problems with shouting or talking with a loud voice?,” Weak or unclear
voice: “Is the child‘s voice so weak or unclear that it limits the possibility of being heard in a noisy environment?,” Voice influences participation in school or social activities: “Is the child‘s
voice influencing participation in school or regular social activities?.” aOR1, adjusted for total number of days on invasive mechanical ventilation; aOR2, adjusted for gestational age; CI,
confidence interval; OR, odds ratio; PDA, patent ductus arteriosus. Values in bold indicates a p-value of less than 0.05.
exercise related respiratory symptoms inmid-childhood, possibly
influenced also by prolonged mechanical ventilation.
Management of PDA in EP-born neonates is debated. Options
include a conservative approach, pharmacologic intervention,
or surgical ligation, the latter usually used as a last resort
(41, 42). Knowledge on long-term outcomes must count in
these discussions. There are few studies reporting on voice
characteristics and exercise related respiratory symptoms in
children and adults exposed to neonatal PDA surgery (30).
Although LVCP is a well-described complication, an unknown
fraction may pass unnoticed or are misinterpreted during the
neonatal period as symptoms may be vague, transient and
uncharacteristic (27, 29, 37, 38, 43). Importantly, we know that
pediatric LVCP does not usually recover (11, 44–46). Therefore,
symptoms may continue to be overlooked or erroneously related
to other disorders or even to malingering, later in life. We do not
have research based data to substantiate this notion. However,
early life events are rarely considered by respiratory specialists
(5), and LVCP is probably not on top of the physicians‘ list
when trying to interpret airway symptoms. In a regional study
of 11 EP born adults who had undergone PDA surgery in the
1980s, seven had LVCP of whom six reported trouble with
their voice. None of them were comfortable with singing or
speaking loudly, and all disclosed prolonged inspirium, wheeze
or stridor when tested on a treadmill (11). Importantly, three
of them had a long history of “difficult-to-treat asthma,” but
they could substantially reduce medication after receiving the
LVCP diagnosis. In our study, we found no association between
PDA surgery and current asthma medication; however, a higher
proportion of the surgically treated children had used asthma
medication. Thus, breathing problems could initially have been
perceived as asthma, and medication subsequently stopped due
to lack of effect.
In the present study, we also identified children with
respiratory and voice related symptoms among children with
no history of PDA, or who had not undergone PDA surgery,
implying that these symptoms are of multi-factorial origin.
Prolonged mechanical ventilation is associated with subglottic
stenosis and injury to the vocal cords (47), which may lead
to stridor and affect voice (48). Walz et al. (25) found that
prolonged intubation (more than 4 weeks) was associated with
long-term reduced voice quality. In univariate analysis, both
the presence of a PDA and surgical closure of a PDA were
associated with lower score on voice related quality of life. In
multivariate analysis, PDA did not contribute to the model, but
PDA surgery was not included. French et al. (26) reported that
58% of school aged children born before 25 weeks’ gestation
had moderate to severe hoarseness, and that the number of
intubations (more than five) was associated with voice disorders.
The authors suggested that the voice abnormalities could be
related to laryngeal injury from endotracheal intubation. As
only three of the 67 tested children had undergone PDA
surgery, they argued that surgery could not have contributed
to the voice problems in their cohort (26). Simpson et al. (21)
found that 25/35 very preterm born children presented with
dysphonia at 11 years of age, and increased dysphonia severity
was predicted by lower GA, increased number of intubations
and days of mechanical ventilation. Only three subjects had
undergone PDA surgery, but they represented 3/14 subjects
with moderate to severe dysphonia. Presence of dysphonia was
associated with reports of previous wheeze, asthma diagnosis
and former use of asthma medications. However, there was no
difference in lung function between groups with- or without
dysphonia, and the authors suggested upper airway pathology
and dysfunctional breathing contributing to increased reports of
respiratory symptoms (21).
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The major limitations of this study were the relatively small
sample size and the fact that we relied on parental observation
of respiratory and voice related symptoms. We know from
asthma research that there are differences between parents’ and
children’s perceptions (49). However, in this age group parental
information is usually what we have to go by in clinical work.
As in all follow-up studies, attrition influences interpretation; in
our case underlined by differences between responders and non-
responders listed in the appendix. Importantly, laryngoscopies
had not been performed, precluding knowledge as to whether
LVCP, or other laryngeal abnormalities contributed to the
increased odds of respiratory and voice related symptoms in the
PDA surgery group. Inability to ascertain why infants exposed
to PDA surgery needed more days on mechanical ventilation
challenged attempts to interpret the role of this variable in
the regression models and thus in the causal chain leading
to symptoms.
CONCLUSION
Extremely preterm born school-children who had undergone
neonatal PDA surgery had more voice and exercise related
respiratory symptoms than children exposed to other modes of
PDA treatment. Although these symptoms are likely to have
a compound etiology, when present in children exposed to
neonatal PDA surgery, they must prompt a search for upper
airway abnormalities, and not lead to empirical prescription of
asthma medication. We must not forget early life events when
dealing with respiratory symptoms.
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